AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,462 | 32,342 | 34,662 | 31,180 | 22,204 |
| Marketable Securities | 70,987 | 77,993 | 100,868 | 122,933 | 139,778 |
| Receivables | 1,636 | 1,180 | 1,977 | 1,965 | 2,212 |
| Other current assets | 293 | 435 | 502 | 618 | 1,029 |
| TOTAL | $102,156 | $116,744 | $142,126 | $159,778 | $169,234 |
| Non-Current Assets | |||||
| PPE Net | 2,625 | 2,401 | 2,759 | 3,018 | 3,071 |
| Investments And Advances | 747 | 705 | 730 | 708 | 651 |
| Intangibles | 64,336 | 60,852 | 62,995 | 61,114 | 56,083 |
| Other Non-Current Assets | 5,500 | 5,480 | 5,814 | 5,971 | 5,769 |
| TOTAL | $73,207 | $69,438 | $72,297 | $70,812 | $65,574 |
| Total Assets | $175,363 | $186,181 | $214,423 | $230,590 | $234,808 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,683 | 2,496 | 1,957 | 3,308 | 2,660 |
| Accrued Expenses | 8,255 | 9,737 | 14,985 | 13,911 | 12,399 |
| TOTAL | $117,718 | $114,294 | $122,808 | $119,970 | $110,401 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 106,727 | 101,033 | 104,561 | 101,491 | 94,194 |
| Other Non-Current Liabilities | 11,316 | 14,888 | 10,217 | 15,657 | 14,552 |
| TOTAL | $17,405 | $17,712 | $13,591 | $20,016 | $18,953 |
| Total Liabilities | $135,122 | $132,006 | $136,399 | $139,986 | $129,354 |
| Shareholders' Equity | |||||
| Common Shares | 2,880 | 2,719 | 2,799 | 2,711 | 2,481 |
| Retained earnings | -577,891 | -529,898 | -524,479 | -493,316 | -429,622 |
| Other shareholders' equity | -269 | -255 | -269 | -259 | -244 |
| TOTAL | $40,241 | $54,175 | $78,024 | $90,604 | $105,453 |
| Total Liabilities And Equity | $175,363 | $186,181 | $214,423 | $230,590 | $234,808 |